Followers | 9 |
Posts | 750 |
Boards Moderated | 0 |
Alias Born | 10/19/2008 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, December 14, 2015 12:30:50 PM
I am confident the human results will be positive, but if very strongly positive, wow, look out.
One thing I have not liked about this company is the cash burn and how close it always is to having zero cash. Yet, the thing that has always impressed me is the achieve a good part of what they say they are doing.
They say they are going to make a side business to help fund the research cash burn; they do it. Not only do they do it, but is shows steady growth and product expansion.
They say they will partner with a Japanese pharma and they do for shared product interests.
They say they will work with the leading university on Parkinsons and perform the needed primate studies to allow human studies; and they do it with good results.
They say they will go to Australia to reduce cost and time to market versus the FDA, a successful path for others; and they do it. Not only do they do it, but get the go-ahead from the authorities to proceed in almost record time. What does that mean, it means real human results are here in 2016. Place your bets on what you think the human patients will say. That is the bottom line!
I am not saying to buy, sell or hold, but this company is quite interesting to say the least. At a 14 million market cap, even if things failed eventually, it is hard not to fathom a 200-400 million market cap at some point in all the chaos and activity. Is that a 10+ banger, maybe. Lets hope for all those longs.
Recent ISCO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:05:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:00:42 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:00:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/08/2023 06:18:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/08/2023 06:17:20 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 09/27/2023 04:27:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2023 12:01:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 06:20:54 PM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM